A Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer
Clinical trial NCT06313983 · RECRUITING
Trial details
- NCT number
- NCT06313983
- Sponsor
- Tianjin Hemay Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-08
- Primary completion
- 2025-12-01
- Enrollment
- 339
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.